Brenton Barnes buys 8,000,000 shares in LBT Innovations Limited (ASX:LBT)

LBT Innovations Limited (ASX:LBT – Get Your Free Report) insider Brenton Barnes acquired 8,000,000 shares of the stock in a transaction dated Friday, August 16th. The shares were bought at an average cost of $0.01 ($0.00) per share, with a total value of $40,000.00 ($27,027.03).

LBT Innovations Price Performance

The company has a debt-to-equity ratio of 129.00, a quick ratio of 2.10, and a current ratio of 4.51.

LBT Innovations Company Profile

(Get a free report)

LBT Innovations Limited is engaged in the research, development and commercialization of technologies for the healthcare and laboratory supply markets in Australia, the United States of America, Sweden, the United Kingdom and Germany. Its product portfolio includes the Independence Automated Plate Assessment System (APAS), a technology platform that automates the screening and interpretation of culture plates; APAS Analysis Modules, intelligent image analysis software that enables screening of microbiology culture plates; APAS Antimicrobial Resistance (AMR) Analysis Module that reads and interprets Antimicrobial Susceptibility Tests (AST) for AMR detection; and APAS PharmaQC, which provides automated imaging, analysis and interpretation of microbiology culture plates used in environmental monitoring.

Read more

Get daily news and reviews for LBT Innovations – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for LBT Innovations and related companies with MarketBeat.com’s FREE daily email newsletter.